Literature DB >> 11245336

Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast.

H S Berner1, J M Nesland.   

Abstract

Expression of CD44 has been shown to correlate with the progression and prognosis of some malignant tumors. The aim of this study was to evaluate the expression of CD44 isoforms in infiltrating lobular carcinomas and analyse their potential as prognostic indicators. A panel of 39 tumors were examined for their expression of membranous and cytoplasmic CD44s, v3, v5, v6, v7 and v3-10 in the infiltrating cells, by immunohistochemical staining. The protein positive tumors showed membranous and/or cytoplasmic staining with all antibodies used except for CD44v7, which only displayed cytoplasmic staining. Cytoplasmic expression of CD44v3 (P = 0.014) and membranous expression of v6 (P = 0.039) were significantly associated with alveolar, classical/alveolar carcinomas and mucinous/alveolar carcinomas. Furthermore, in alveolar, classical/alveolar and mucinous/alveolar carcinomas, cytoplasmic staining of CD44v5 was correlated with lymph node negative patients (P = 0.048), whereas membranous v5 was correlated with lymph positive patients (P = 0.048). In classical, classical/trabecular and trabecular carcinomas expression of membranous CD44s was significantly correlated with lymph node status (P = 0.042).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11245336     DOI: 10.1023/a:1006417412046

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast.

Authors:  G M K Tse; P-H Tan; T K F Ma; C B Gilks; C S P Poon; B K B Law
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Prognostic value of CD44 expression in penile squamous cell carcinoma: a pilot study.

Authors:  Daniele Minardi; Guendalina Lucarini; Alessandra Filosa; Antonio Zizzi; Oriana Simonetti; Anna Maria Offidani; Gianluca d'Anzeo; Roberto Di Primio; Rodolfo Montironi; Giovanni Muzzonigro
Journal:  Cell Oncol (Dordr)       Date:  2012-09-13       Impact factor: 6.730

3.  Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.

Authors:  Yong-Jun Liu; Pei-Song Yan; Jun Li; Jing-Fen Jia
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

4.  Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.

Authors:  S Julien; M A Krzewinski-Recchi; A Harduin-Lepers; V Gouyer; G Huet; X Le Bourhis; P Delannoy
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

5.  High throughput identification of monoclonal antibodies to membrane bound and secreted proteins using yeast and phage display.

Authors:  Lequn Zhao; Liang Qu; Jing Zhou; Zhengda Sun; Hao Zou; Yunn-Yi Chen; James D Marks; Yu Zhou
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

6.  DNA aptamers against exon v10 of CD44 inhibit breast cancer cell migration.

Authors:  Joji Iida; Rebecca Clancy; Jesse Dorchak; Richard I Somiari; Stella Somiari; Mary Lou Cutler; Richard J Mural; Craig D Shriver
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

7.  Collective invasion in ductal and lobular breast cancer associates with distant metastasis.

Authors:  Antoine A Khalil; Olga Ilina; Pavlo G Gritsenko; Peter Bult; Paul N Span; Peter Friedl
Journal:  Clin Exp Metastasis       Date:  2017-09-11       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.